**Author details**

Darryl R. Peterson1,2\* and Ernest J. Sukowski1

1 Discipline of Physiology and Biophysics, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA

2 Discipline of Medicine, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA

\*Address all correspondence to: darryl.peterson@rosalindfranklin.edu

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**213**

*Prevention of Oxidative Injury Associated with Thrombolysis for Ischemic Stroke*

Medicine. 2018;**2**:1-16. DOI: 10.24150/

[9] Todd NV, Picozzi P, Crockard A, Russell RW. Duration of ischemia influences the development and resolution of ischemic brain edema.

[10] Warach S, Latour LL. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging maker of early blood-brain barrier disruption. Stroke. 2004;**35**:2659-2661. DOI: 1161/01.STR.0000144051.32131.09

[11] Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. The New England Journal of Medicine. 2008;**359**:1317-1329. DOI: 10.1056/

[12] Gartshore G, Patterson J, Macrae IM. Influence of ischemia and reperfusion on the course of brain tissue swelling and blood–brain barrier permeability in a rodent model of transient focal cerebral ischemia. Experimental Neurology. 1997;**147**: 353-360. DOI: 10.1006/exnr.1997.6635

[13] Wang X, Tsuji K, Lee SR, et al. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke. 2004;**35**:2726-2730. DOI: 1161/01.STR.0000143219.16695.af

[14] Khatri R, McKinney AM, Swenson B, et al. Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology. 2012;**79**:S52-S57. DOI: 10.1212/ WNL.0b013e3182697e70

[15] Nour M, Scalzo F, Liebeskind DS. Ischemia-reperfusion injury in stroke. Interventional Neurology. 2012;**1**:185-199. DOI: 10.1159/000353125

NEJMoa0804656

ajhm/2018.001

Stroke. 1986;**17**:466-471

*DOI: http://dx.doi.org/10.5772/intechopen.84774*

[1] Thrift AG, Thayabaranathan T, Howard G, et al. Global stroke statistics. International Journal of Stroke. 2017;**12**:13-32. DOI: 10.1177/1747493016676285

**References**

[2] Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics—2016 update: A report from the American Heart Association. Circulation. 2016;**133**:e38-e60. DOI: 10.1161/CIR.0000000000000350

[3] Emberson J, KR L, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomized trials. Lancet. 2014;**384**:1929-1935. DOI:

10.1016/S0140-6736(14)60584-5

[4] Nasr DM, Brinjikji W, Cloft HJ, et al. Utilization of intravenous thrombolysis is increasing in the United States. International Journal of Stroke. 2013;**8**:681-688. DOI: 10.1111/j.1747-4949.2012.00844.x

[5] Musuka TD, Wilton SB, Traboulsi M, et al. Diagnosis and management of acute ischemic stroke: Speed is critical. CMAJ. 2015;**187**:887-893. DOI: 10.1503/

[6] Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al. Scientific rationale for the inclusion and exclusion for intravenous alteplase in acute ischemic stroke. Stroke. 2016;**47**:581-641. DOI: 10.1161/STR.0000000000000086

[7] Catanese L, Tarsia J, Fisher M. Acute ischemic stroke therapy overview. Circulation Research. 2017;**120**:541-558. DOI: 10.1161/CIRCRESAHA.116.309278

management review for the hospitalist.

[8] Haldal S, Beary J, Nattanmai PC, et al. Acute ischemic stroke

American Journal of Hospital

cmaj.140355

*Prevention of Oxidative Injury Associated with Thrombolysis for Ischemic Stroke DOI: http://dx.doi.org/10.5772/intechopen.84774*
